» Articles » PMID: 21724611

MicroRNA-296 is Enriched in Cancer Cells and Downregulates P21WAF1 MRNA Expression Via Interaction with Its 3' Untranslated Region

Overview
Specialty Biochemistry
Date 2011 Jul 5
PMID 21724611
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are a class of noncoding small RNAs that act as negative regulators of gene expression. To identify miRNAs that may regulate human cell immortalization and carcinogenesis, we performed comparative miRNA array profiling of human normal and SV40-T antigen immortalized cells. We found that miR-296 was upregulated in immortalized cells that also had activation of telomerase. By an independent experiment on genomic analysis of cancer cells we found that chromosome region (20q13.32), where miR-296 is located, was amplified in 28/36 cell lines, and most of these showed enriched miR-296 expression. Overexpression of miR-296 in human cancer cells, with and without telomerase activity, had no effect on their telomerase function. Instead, it suppressed p53 function that is frequently downregulated during human cell immortalization and carcinogenesis. By monitoring the activity of a luciferase reporter connected to p53 and p21(WAF1) (p21) untranslated regions (UTRs), we demonstrate that miR-296 interacts with the p21-3'UTR, and the Hu binding site of p21-3'UTR was identified as a potential miR-296 target site. We demonstrate for the first time that miR-296 is frequently upregulated during immortalization of human cells and contributes to carcinogenesis by downregulation of p53-p21(WAF1) pathway.

Citing Articles

A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma.

Komitova K, Dimitrov L, Stancheva G, Kyurkchiyan S, Petkova V, Dimitrov S Int J Mol Sci. 2025; 25(24.

PMID: 39769234 PMC: 11676902. DOI: 10.3390/ijms252413468.


MicroRNAs role in telomere length maintenance and telomerase activity in tumor cells.

Bortoletto S, Nunes-Souza E, Marchi R, Ruthes M, Okano L, Tofolo M J Mol Med (Berl). 2024; 102(9):1089-1100.

PMID: 39042290 DOI: 10.1007/s00109-024-02467-z.


3'UTR of SARS-CoV-2 spike gene hijack host miR-296 or miR-520h to disturb cell proliferation and cytokine signaling.

Yuan J, Feng Z, Wang Q, Han L, Guan S, Liu L Front Immunol. 2022; 13:924667.

PMID: 36238276 PMC: 9552351. DOI: 10.3389/fimmu.2022.924667.


Molecular Insights into the Antistress Potentials of Brazilian Green Propolis Extract and Its Constituent Artepillin C.

Kaul A, Kuthethur R, Ishida Y, Terao K, Wadhwa R, Kaul S Molecules. 2022; 27(1).

PMID: 35011307 PMC: 8746355. DOI: 10.3390/molecules27010080.


Functional characterization of miR-708 microRNA in telomerase positive and negative human cancer cells.

Kaul Z, Cheung C, Bhargava P, Sari A, Yu Y, Huifu H Sci Rep. 2021; 11(1):17052.

PMID: 34426596 PMC: 8382839. DOI: 10.1038/s41598-021-96096-y.


References
1.
Bonauer A, Boon R, Dimmeler S . Vascular microRNAs. Curr Drug Targets. 2010; 11(8):943-9. DOI: 10.2174/138945010791591313. View

2.
Zhang C . MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics. 2008; 33(2):139-47. DOI: 10.1152/physiolgenomics.00034.2008. View

3.
Corney D, Flesken-Nikitin A, Godwin A, Wang W, Nikitin A . MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 2007; 67(18):8433-8. DOI: 10.1158/0008-5472.CAN-07-1585. View

4.
Barbarotto E, Schmittgen T, Calin G . MicroRNAs and cancer: profile, profile, profile. Int J Cancer. 2007; 122(5):969-77. DOI: 10.1002/ijc.23343. View

5.
Zhang L, Volinia S, Bonome T, Calin G, Greshock J, Yang N . Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A. 2008; 105(19):7004-9. PMC: 2383982. DOI: 10.1073/pnas.0801615105. View